RSK2: a promising therapeutic target for the treatment of triple-negative breast cancer.

Expert Opin Ther Targets

Phoenix Molecular Designs, Vancouver, British Columbia, Canada.

Published: January 2020

Download full-text PDF

Source
http://dx.doi.org/10.1080/14728222.2020.1709824DOI Listing

Publication Analysis

Top Keywords

rsk2 promising
4
promising therapeutic
4
therapeutic target
4
target treatment
4
treatment triple-negative
4
triple-negative breast
4
breast cancer
4
rsk2
1
therapeutic
1
target
1

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!